According to Alkermes's latest financial reports the company's current revenue (TTM) is $1.66 B. In 2022 the company made a revenue of $1.11 B a decrease over the years 2021 revenue that were of $1.17 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $1.66 B | 49.61% |
2022 | $1.11 B | -5.28% |
2021 | $1.17 B | 13% |
2020 | $1.03 B | -11.29% |
2019 | $1.17 B | 7.01% |
2018 | $1.09 B | 21.13% |
2017 | $0.90 B | 21.15% |
2016 | $0.74 B | 18.68% |
2015 | $0.62 B | 1.54% |
2014 | $0.61 B | |
2012 | $0.54 B | 74.67% |
2011 | $0.31 B | 78.55% |
2010 | $0.17 B | -5.28% |
2009 | $0.18 B | -46.82% |
2008 | $0.34 B | 42.04% |
2007 | $0.24 B | 6.28% |
2006 | $0.22 B | 68.25% |
2005 | $0.13 B | 96.57% |
2004 | $69.17 M | 96.06% |
2003 | $35.28 M | -25.84% |
2002 | $47.57 M | -7.34% |
2001 | $51.34 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $93.02 B | 5,492.26% | ๐บ๐ธ USA |
Novartis NVS | $51.01 B | 2,966.72% | ๐จ๐ญ Switzerland |
Pfizer PFE | $58.49 B | 3,416.70% | ๐บ๐ธ USA |
Sanofi SNY | $50.35 B | 2,927.52% | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | $45.00 B | 2,605.65% | ๐บ๐ธ USA |
AstraZeneca AZN | $45.81 B | 2,654.05% | ๐ฌ๐ง UK |
Zogenix ZGNX | $81.69 M | -95.09% | ๐บ๐ธ USA |
Acorda Therapeutics
ACOR | $0.11 B | -93.32% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $15.84 B | 852.62% | ๐ฎ๐ฑ Israel |